HC Wainwright Lowers Ikena Oncology (NASDAQ:IKNA) Price Target to $11.00
Ikena Oncology (NASDAQ:IKNA – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $11.00 in a report issued on Thursday, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Wedbush started coverage on shares of Ikena Oncology in a research note on Thursday, September 21st. They issued […]
More Stories
Douglas Lane & Associates LLC Reduces Position in Simon Property Group, Inc. (NYSE:SPG)
Douglas Lane & Associates LLC lowered its stake in Simon Property Group, Inc. (NYSE:SPG – Free Report) by 2.4% in...
Truist Financial Co. (NYSE:TFC) Shares Sold by Douglas Lane & Associates LLC
Douglas Lane & Associates LLC trimmed its stake in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 2.9%...
Douglas Lane & Associates LLC Cuts Stake in Diageo plc (NYSE:DEO)
Douglas Lane & Associates LLC lessened its position in Diageo plc (NYSE:DEO – Free Report) by 20.2% during the 4th...
Douglas Lane & Associates LLC Decreases Position in Kyndryl Holdings, Inc. (NYSE:KD)
Douglas Lane & Associates LLC trimmed its holdings in shares of Kyndryl Holdings, Inc. (NYSE:KD – Free Report) by 1.9%...
Shearwater Capital LLC Has $12.67 Million Stock Position in Dimensional International Value ETF (NYSEARCA:DFIV)
Shearwater Capital LLC raised its stake in Dimensional International Value ETF (NYSEARCA:DFIV – Free Report) by 0.5% during the fourth...
12,042 Shares in Dimensional US High Profitability ETF (NYSEARCA:DUHP) Acquired by Shearwater Capital LLC
Shearwater Capital LLC purchased a new stake in Dimensional US High Profitability ETF (NYSEARCA:DUHP – Free Report) during the 4th...